Is this time frame new for you or have you always had this expectation for the finale?

What do you think the SP will do after ASCO and what is your expectation for end of year when Kevetrin finishes P1?

I don't mind the 18-24 mo. as long as we see substantial price increase this summer into the end of the year as both Prurisol and Kevetrin will be shown to work and the following P2/P3 trials I don't think are that great a risk do to preclinical results.  I also think once we get the positive news re: both P & K big pharma isn't going to sit for another year without offering the amt of money Leo will be asking so I will be surprised if CTIX lasts that long;  also believe SP goes very strongly from the summer til the end of the year.

I'm slow, didn't understand your avatar/bowling ball reference.